Table 3.

Success rates for AM therapy

Pathological condition	Success (%)	Partial success (%)	Failure (%)
Corneal ulcers including neurotrophic keratitis	100
Keratitis/endophthalmitis	90	10
Pterygium	71	21	8
Post keratoplasty, glaucoma or cataract	100
Chemical trauma	15	61	24
Bullous keratopathy	100
Neoplasia of the ocular surface	50	17	33
Reconstruction of the conjunctiva and fornix	30	23	47
Corneal degeneration	100
Recurrent epithelial erosions	85	10	5
Primary and secondary limbal stem cell deficiency	18	50	32
Mucous membrane pemphigoid	10	11	79
Dystrophy	100
Mechanical trauma	100
Stevens–Johnson or Lyell’s syndrome	19	19	62
Reconstruction of the anophthalmic cavity	100
Physical trauma	70		30
Eyelid reconstruction	100
Dysfunctional tear syndrome	100
Other	29	17	54

Data on success rates for AM ocular therapies between 2003 and 2014